Advertisement

ADVERTISEMENT

Noncolorectal

TAS-118 Plus Oxaliplatin Potential New Standard Therapy for Advanced Gastric Cancer
07/04/2019
Findings from the phase 3 SOLAR trial suggest TAS-118 plus oxaliplatin is a potential new, standard first-line chemotherapy for the treatment of patients with advanced gastric cancer.
Findings from the phase 3 SOLAR trial suggest TAS-118 plus oxaliplatin is a potential new, standard first-line chemotherapy for the treatment of patients with advanced gastric cancer.
Findings from the phase 3 SOLAR...
07/04/2019
Oncology
Pembrolizumab Fails to Achieve Goal Response Rate in Patients With Advanced Small Bowel Adenocarcinoma
07/04/2019
A recent trial assessing the activity of pembrolizumab in pretreated patients with advanced small bowel adenocarcinoma did not meet its primary end point of confirmed overall response in this population.
A recent trial assessing the activity of pembrolizumab in pretreated patients with advanced small bowel adenocarcinoma did not meet its primary end point of confirmed overall response in this population.
A recent trial assessing the...
07/04/2019
Oncology
Ibrutinib Plus Nab-Paclitaxel/Gemcitabine Yields No Survival Benefit in Metastatic Pancreatic Cancer
07/04/2019
Ibrutinib plus nab-paclitaxel/gemcitabine did not improve survival in patients with pancreatic ductal adenocarcinoma in a recent clinical trial.
Ibrutinib plus nab-paclitaxel/gemcitabine did not improve survival in patients with pancreatic ductal adenocarcinoma in a recent clinical trial.
Ibrutinib plus...
07/04/2019
Oncology
Olaparib Maintenance Therapy Extends Survival in Patients With Metastatic Pancreatic Cancer
07/03/2019
Maintenance therapy with olaparib significantly reduced the risk for disease progression or death in patients with metastatic pancreatic cancer, according to data from the POLO trial.
Maintenance therapy with olaparib significantly reduced the risk for disease progression or death in patients with metastatic pancreatic cancer, according to data from the POLO trial.
Maintenance therapy with...
07/03/2019
Oncology
Nab-Paclitaxel Plus Gemcitabine May Be Viable for Patients With Pancreatic Cancer
07/03/2019
Results from a recent study suggest that adjuvant nab-paclitaxel plus gemcitabine may be a viable option for patients with pancreatic cancer ineligible for adjuvant FOLFIRINOX.
Results from a recent study suggest that adjuvant nab-paclitaxel plus gemcitabine may be a viable option for patients with pancreatic cancer ineligible for adjuvant FOLFIRINOX.
Results from a recent study...
07/03/2019
Oncology
Gastric Cancer Rates Have Increased in Younger Latin Women in Past Decade
07/02/2019
Rates of gastric cancer have increased in the past decade more for women than men and for people aged ≤40 years than for those >40 years.
Rates of gastric cancer have increased in the past decade more for women than men and for people aged ≤40 years than for those >40 years.
Rates of gastric cancer have...
07/02/2019
Oncology
Videos
David Ilson, MD, PhD, on Adjuvant Treatment Options for Patients With Gastric Cancer
05/07/2019
In this 3-part video series, Dr Ilson discusses the current adjuvant treatment landscape for patients with gastric cancer.
In this 3-part video series, Dr Ilson discusses the current adjuvant treatment landscape for patients with gastric cancer.
In this 3-part video series, Dr...
05/07/2019
Oncology
Videos
Tanios S. Bekaii-Saab, MD, Talks Optimal Second-Line HCC Therapy With Cabozantinib
04/17/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Bekaii-Saab discussed the role of cabozantinib in the second-line HCC therapy.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Bekaii-Saab discussed the role of cabozantinib in the second-line HCC therapy.
At the 2019 Great Debates &...
04/17/2019
Oncology
Videos
Jordan D. Berlin, MD, on the Role of Pre-Op Chemo in Pancreatic Cancer
04/17/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed the role of pre-surgery chemotherapy in pancreatic cancer.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed the role of pre-surgery chemotherapy in pancreatic cancer.
At the 2019 Great Debates &...
04/17/2019
Oncology
Videos
Tanios S. Bekaii-Saab, MD, Discusses Sequencing of Agents in HCC Therapy
04/03/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Bekaii-Saab discussed how to best sequence drugs in the treatment of HCC.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Bekaii-Saab discussed how to best sequence drugs in the treatment of HCC.
At the 2019 Great Debates &...
04/03/2019
Oncology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 18 ⁠–⁠ September 20
September 20 ⁠–⁠ September 22
September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use